baber/WOPTO huggingface dataset:
Patent NZ-518007-A (NZ)
Title: Pharmaceutical compositions of metalloproteinase fibrinolytic agent
Inventor: KENDRICK BRENT S
IPC: A61K38/48
Filed: 2000-09-29
Abstract: Frozen and lyophilized compositions for a metalloproteinase fibrinolytic agent (fibrolase or novel acting thrombolytic (NAT)), a method for preparing the lyophilized composition, and a kit and method for reconstituting the lyophilized composition are disclosed. A pharmaceutical composition comprising a metalloproteinase fibrinolytic agent selected from the group consisting of fibrolase and novel acting thrombolytic (NAT)), a zinc stabilizer and, optionally, a bulking agent, in a pharmaceutically acceptable buffer is disclosed.
Patent NZ-519124-A (NZ)
Title: Electronic detenator system with detenator having flags for communication and detonation
Inventor: BOKVIST ANNE-MARIE
IPC: F42C19/08
Filed: 2000-12-06
Abstract: An electronic detonator system which comprises a control unit, a plurality of electronic detonators and a bus which connects said detonators to the control unit. Each electronic detonator comprises a number of flags which may assume either of two possible values, each flag indicating a substate of the respective detonators. The flags are readable from the control unit by means of digital data packets and the control unit is adapted, by means of these flags, to check the state of the electronic detonator and control the operation of the electronic detonator. When reading said flags, the electronic detonators give responses in the form of analog response pulses on the bus. The detonator system also comprises a portable message receiver which on the basis of said flags obtains messages regarding the connecting status of a detonator
Patent NZ-520376-A (NZ)
Title: Therapeutic or preventive agent for pulmonary insufficiency containing a diaminotrifluoromethylpyridine derivative
Inventor: MORINO KYUYA
IPC: A61P/
Filed: 2001-01-30
Abstract: Remedies or preventives for pulmonary insufficiency which contain as the active ingredient diaminotrifluoromethylpyridine derivatives represented by the following general formula (I) or its salts are disclosed, wherein X represents CW1R1, -COCOR2, CW1NHCOR2, -C(=W1)W2R3 or -CW1N(R4)R5; and Y represents alkyl, -CW3R6, -COCOR7, -NHCOR7, -C(=W3)W4R8, -(NH)mSO2R9, -(NH)mSO2OR10 or -(NH)mSO2N(R11)R12 (wherein R1, R6 and R9 represent each chain hydrocarbyl, monocyclic hydrocarbyl, polycyclic hydrocarbyl, a monocyclic heterocycle or a polycyclic heterocycle; R2 and R7 represent each alkyl, alkoxy, phenyl or phenoxy; R3, R8 and R10 represent each alkyl, alkenyl, alkynyl, cycloalkyl, phenyl or benzyl; R4, R5, R11 and R12 represent each alkyl; W1, W2, W3 and W4 represent each oxygen or sulfur; and m is 0 or 1).
Patent NZ-523995-A (NZ)
Title: Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
Inventor: CHRISTENSSON ANNA CAMILLA
IPC: A61K39/00
Filed: 2001-08-08
Abstract: Polynucleotides isolated from lactic acid bacteria, namely Lactobacillus rhamnosus, including full-length sequences encoding polypeptides, as well as to probes and primers specific to these polynucleotides are disclosed.
Patent NZ-530179-A (NZ)
Title: A veterinary table
Inventor: DRZYMALA NORBERT
Filed: 2001-06-08
Abstract: A veterinary table (10) that includes a platform (tabletop) (11) to receive an animal thereon, a lower frame (13) adjacent a ground (support) surface, supporting means supporting the platform above the lower frame, the supporting means being adapted to raise and lower the platform relative to the frame. The supporting means includes at least one pair of struts (15, 16) pivotally coupled together and diagonally coupling the platform and the lower frame. One of the struts (15) is coupled by a fixed pivot (13a) to the lower frame and coupled by a sliding pivot (20a) to the platform. The other of the struts (16) is coupled by a sliding pivot (19a) to the lower frame and coupled by a fixed pivot (17a) to an additional frame (17) that is pivotally coupled to the platform. A first ram (34) is coupled between the platform and the lower frame to, in use, raise and lower the platform. A second ram (38) is coupled between the platform and the additional frame to, in use, enable the platform to be tilted relative to the lower frame.
Patent NZ-536197-A (NZ)
Title: 3-substituted quinuclidines and their use
Inventor: PETERS DAN
IPC: A61P25/16
Filed: 2003-05-27
Abstract: Disclosed are 3-substiuted quinuclidine compounds of formula (V), or Formula (VII), wherein: R1 and R2 are independently H, alkyl, cycloalkyl, cycloalkylalkyl, alkoxy, alkoxyalkyl, hydroxyalkoxy, halo, haloalkyl, hydroxyl, haloalkoxy, cyano, amino, nitro or phenyl. The compounds are used in the manufacture of medicaments for the treatment of conditions responsive to modulation of cholinergic receptors and/or monoamine receptors.
Patent NZ-537217-A (NZ)
Title: LMW-N-sulphates useful as intermediates in the preparation of LMW-K5-N, O oversulfates with antiviral and/or antiangiogenic activity and devoid of anticoagulant activity
Inventor: ORESTE PASQUA ANNA
IPC: C08B37/00
Filed: 2003-06-17
Abstract: LMW-K5-N,O-oversulfates are described, having a sulfation degree of from 3.2 to 4 and a mean molecular weight of from about 3,000 to about 6,000, obtained by depolymerization of corresponding K5-N,O-oversulfates or starting from LMW-K5-N-sulfates by O-oversulfation of a tertiary amine or quaternary ammonium salt thereof and subsequent N-resulfation of the K5-amine-O-oversulfate thus obtained. Furthermore, pharmaceutical compositions containing these LMW-K5-N,O-oversulfates having antiangiogenetic and antiviral, in particular anti-HIV-1 activity are described. Intermediate LMW-K5-N-sulfates are also described.
Patent NZ-543005-A (NZ)
Title: Compositions containing piperacillin and tazobactam useful for injection
Inventor: COHEN JONATHAN MARC
IPC: A61K47/18
Filed: 2004-04-07
Abstract: Disclosed is a pharmaceutical composition useful for the treatment or control of bacterial infections by parenteral administration, the composition comprising effective amounts of (a) piperacillin or a pharmaceutically acceptable salt thereof, (b) tazobactam or a pharmaceutically acceptable salt thereof and an aminocarboxylic acid chelating agent or a pharmaceutically acceptable salt thereof. Also disclosed is a process for the manufacture of a pharmaceutical composition useful for the treatment or control of bacterial infections by parenteral administration, the pharmaceutical composition being in the form of a powder that can be reconstituted by addition of a compatible reconstitution diluent prior to parenteral administration or in the form of a frozen composition adapted to be thawed and, if desired, diluted with a compatible diluent prior to parenteral administration; which process comprises freezing or freeze-drying a solution containing effective amounts of (a) piperacillin or a pharmaceutically acceptable salt thereof, (b) tazobactam or a pharmaceutically acceptable salt thereof and an aminocarboxylic acid cheating agent or a pharmaceutically acceptable salt thereof in an aqueous vehicle.
Patent NZ-543780-A (NZ)
Title: A system and method for treating wastewater using coir filter
Inventor: THEOPHILUS TERRY B
IPC: C02F3/04
Filed: 2004-04-05
Abstract: Disclosed is a method of treating wastewater, comprising a) placing coir material in a biotreatment container having an inlet and an outlet; b) introducing wastewater into the biotreatment container; c) percolating the wastewater through the coir material and producing an effluent; and d) removing the effluent from the biotreatment container.
Patent NZ-544460-A (NZ)
Title: Nasal pharmaceutical composition of piribedil
Inventor: ROLLAND HERVE
IPC: A61P9/08
Filed: 2004-07-16
Abstract: Provided is a pharmaceutical composition in the form of an aqueous solution or powder for the nasal administration, comprising piribedil or a pharmaceutically acceptable salt thereof. The composition may further comprise cyclodextrin. Also provided are specific dosages of the components.
Patent NZ-547859-A (NZ)
Title: Treatment method and composition for mastitis
Inventor: BRAGGER JUDITH MARY
Filed: 2006-06-09
Abstract: Disclosed is a method of treating or preventing bovine mastitis using a treatment compound which includes at least two components which have an isoelectric point of or above substantially 6.8 and is extracted from milk or a milk derived substance, the method characterised by the step of applying the treatment compound onto or into at least one bovine teat.
Patent NZ-555623-A (NZ)
Title: Method for controlling mycoses in leguminous plants
Inventor: SPEAKMAN JOHN-BRYAN
Filed: 2005-12-16
Abstract: Provided is a method for controlling rust infections in leguminous plants, wherein a combination of orysastrobin with at least one active specified compound selected from the group below is used: azoles, acylalanines, amine derivatives, anilinopyrimidines, dicarboximides, dithiocarbamates, heterocyclic compounds, phenylpyrroles, other fungicides, phosphorous acid or its salts, iprovalicarb, metrafenone, cinnamides and analogs; which comprises orysastrobin and the active compound in a weight ratio of from 100:1 to 1:100. Further provided are corresponding fungicidal mixtures and seeds comprising the mixture.
Patent NZ-562896-A (NZ)
Title: Method of connecting flexible tubing by resilient deformation of tube ends, with other than flanked rib connection
Inventor: MCPHEAT BLAIR FORRES
IPC: F16L47/06
Filed: 2006-05-12
Abstract: Disclosed is a method of connecting a flexible tube for powder transfer between a discharge tube and an receiving tube. The flexible tube ends are deformed inwardly so as to resiliently spring back to connect with adjacent tube ends. At least one connection is other than a flanked rib type connection. Such a connection is not shown in the drawings.
Patent NZ-564191-A (NZ)
Title: Gellan seamless breakable capsule and process for manufacturing thereof
Inventor: HARTMANN DIDIER
IPC: A23L27/00
Filed: 2006-06-21
Abstract: The disclosure relates to a process for manufacturing a seamless breakable capsule, comprising - co-extruding an external and hydrophilic liquid phase, and an internal and lipophilic liquid phase, in order to form a capsule constituted of a core comprising the internal and lipophilic phase, and a shell comprising the external and hydrophilic phase, - immersing into an aqueous solution containing a curing agent , wherein the external liquid phase includes a gelling agent comprising gellan gum alone or in combination with another gelling agent, a filler, and a divalent metal sequestering agent, and to breakable capsules comprising a core and a shell, wherein the shell includes a gelling agent comprising gellan gum alone or in combination with another gelling agent, a filler, and a divalent metal sequestering agent.
Patent NZ-564369-A (NZ)
Title: 5-[2-propyloxy-5(1-methyl-2-pyrrolidinylethylamidosulphonyl)phenyl]-1-methyl-propyl-1,6-dihydro-7H-pyrazolo(4,3-d)pyrimidin-7-one for the prevention and treatment of liver diseases
Inventor: CHOI SEUL MIN
IPC: A61K31/519
Filed: 2005-10-21
Abstract: 5-[2-propyloxy-5-(1-methyl-2-pyrrolidinylethylamidosulphonyl)phenyl]-1-methyl-propyl-1,6-dihydro-7H-pyrazolo(4,3-d)pyrimidin-7-one is a hepatic fibrosis inhibitor and is useful for the treatment and prevention of liver cirrhosis and complications caused by portal hypertension including esophageal varices, splenic enlargement, hypersplenism, ascites, spontaneous bacterial peritonitis, hepatorenal syndrome, hepatopulmonary syndrome and hepatic encephalopathy.
Patent NZ-575643-A (NZ)
Title: Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments
Inventor: HAY MICHAEL PATRICK
IPC: C07D253/10
Filed: 2005-03-31
Abstract: Disclosed is a compound of Formula I or a pharmacologically acceptable salt thereof wherein W represents NH, NMe or CH2, Z represents an optionally substituted 4-8 membered saturated ring system fused to the benzo ring in the 6,7 positions or the 7,8 positions, and wherein the rest of the substituents are disclosed within the specification. Also disclosed is the methods of manufacturing compounds of Formula I and the use of the compound of Formula I in the preparation of a medicament for treating cancer. (62) Divided Out of 561931
Patent NZ-587605-A (NZ)
Title: Methods for the conversion of plant materials into fuels and chemicals by sequential action of two microorganisms
Inventor: LATOUF WILLIAM G
IPC: C12M3/00
Filed: 2009-02-27
Abstract: Disclosed is a process for making ethanol and other chemicals, comprising: providing a pretreated biomass-derived material comprising a plant polysaccharide; inoculating the pretreated biomass-derived material with a first culture comprising a cellulolytic aerobic microorganism in the presence of oxygen to generate an aerobic broth, wherein the aerobic microorganism is capable of at least partially hydrolyzing the plant polysaccharide; incubating the aerobic broth until the cellulolytic aerobic microorganism consumes at least a portion of the oxygen and hydrolyzes at least a portion of the plant polysaccharide, thereby converting the aerobic broth into an anaerobic broth comprising a hydrolysate comprising fermentable sugars; inoculating the anaerobic broth with a second culture comprising an anaerobic microorganism capable of converting fermentable sugars into ethanol and other chemicals; and fermenting the inoculated anaerobic broth until at least a portion of the fermentable sugars have been converted into ethanol and other chemicals. Further disclosed is a process for making a material suitable as a fuel, comprising: providing a plant-derived material comprising a polysaccharide; inoculating the plant-derived material with a first culture comprising a cellulolytic aerobic microorganism to generate a broth, wherein the aerobic microorganism is capable of at least partially hydrolyzing the polysaccharide; incubating the broth in the presence of oxygen such that at least a portion of the polysaccharide is hydrolyzed to one or more sugar species; incubating the broth under conditions to reduce the oxygen concentration so as to convert the broth to an anaerobic broth; inoculating the anaerobic broth with a second culture comprising an anaerobic microorganism capable of converting the one or more sugar species into a material suitable as a fuel; fermenting the inoculated anaerobic broth to produce a material suitable as a fuel Further disclosed is a process for making ethanol and other chemicals, comprising: providing a biomass-derived material comprising a plant polysaccharide; incubating the biomass-derived material with a first culture comprising cell of Clostridium phytofermentans under anaerobic conditions to hydrolyze at least a portion of the plant polysaccharide wherein the cells of the culture incorporate at least a portion of the hydrolyzed plant polysaccharide as an intracellular compound; lysing the cells of Clostridium phytofermentans to produce a lysed broth; inoculating the lysed broth with a second culture comprising an anaerobic microorganism capable of converting fermentable sugars into ethanol and/or other chemicals; and fermenting the inoculated anaerobic broth until at least a portion of the fermentable sugars have been converted into ethanol and/or other chemicals.
Patent NZ-594884-A (NZ)
Title: Otic compositions useful for the treatment of infections of the internal and external ear in mammals
Inventor: CAPRIOTTI JOSEPH A
IPC: A61K31/79
Filed: 2010-02-24
Abstract: 594884 Disclosed herein is the use of a composition comprising povidone iodine (PVP-I) at a concentration of 0.01%-5.0% weight/weight and a steroid such as a dexamethasone, a fluromethalone, a lotoprendol, a medrysone, a prednisolone, a difluprednate, a rimexolone, or a hydrocortisone at a concentration of 0.01%-2.0% weight/weight in the treatment of an octic infection, such as bacterial otitis externa, malignant otitis, fungal otitis externa, otomycosis, otitis media, and otitis interna.
Patent NZ-595941-A (NZ)
Title: Treatment of neurodegeneration and neuroinflammation
Inventor: LUKASHEV MATVEY
IPC: A61K31/195
Filed: 2010-04-29
Abstract: 595941 Discloses the use of dimethyl fumarate in the preparation of a medicament for the treatment of a subject having multiple sclerosis, wherein the medicament is formulated for administration of a first dose of the medicament for a first dosing period and administration of a second dose of the medicament for a second dosing period, wherein the first does of the medicament comprises 120mg dimethyl fumarate formulated for oral administration two or three times per day for the first dosing period, and wherein the second dose of comprises 240mg dimethyl fumarate and is formulated for oral administration two times per day (BID) for the second dosing period.
Patent NZ-599565-A (NZ)
Title: Heterocyclic sulfonamide derivatives useful as mek inhibitors
Inventor: BOCK MARK G
IPC: A61K31/4355
Filed: 2010-11-02
Abstract: 599565 The present disclosure relates to compounds of Formula (IA) Where R1a, R1b, X, R2a, R2b, W, R3, R4, and R5 are as defined herein as well as pharmaceutically acceptable salts thereof. The compounds have been shown to act as MEK inhibitors which may be useful in the treatment of hyperproliferative diseases, like cancer and inflammation. Examples of compounds are: Cyclopropanesulfonic acid [7-(2-fluoro-4-iodo-phenylamino)-6-methyl-5-oxo-2, 3-dihydro-5H-oxazolo[3,2-a]pyridin-8-yl]-amide; 2-Hydroxymethyl-cyclopropanesulfonic acid [7-(2-fluoro-4-iodophenylamino)-6-methyl-5-oxo-2,3-dihydro-5H-oxazolo[3,2-a]pyridin-8-yl]-amide and 1-(2-Hydroxy-ethyl)-cyclopropanesulfonic acid [7-(2-fluoro-4-iodophenylamino)-6-methyl-5-oxo-2,3-dihydro-5H-oxazolo[3,2-a]pyridin-8-yl]-amide.
Patent NZ-603393-A (NZ)
Title: System and process for production of biofuels
Inventor: BATHURST CHRISTOPHER FRANCIS
IPC: C12M1/00
Filed: 2011-05-05
Abstract: Disclosed herein is a process for treating an organic feedstock, wherein the organic feedstock including a convertible component is preprocessed to increase the concentration of the convertible component, the organic feedstock is processed to convert at least a portion of the convertible component to a fuel and the fuel is extracted from the organic feedstock. Further disclosed is a continuous process of producing fuel from an organic feedstock comprising algae, the process comprising the steps of: pre-processing the organic feedstock to increase the concentration of the algae to greater than or equal to 35% by weight of the organic feedstock, wherein the pre-processing steps comprise: (a) heating the organic feedstock to a temperature above 70⁰C for approximately 90 seconds; and (c) removing excess water from the organic feedstock to produce a concentrated pumpable organic feedstock; and further processing the concentrated pumpable organic feedstock by: (e) adding at least one additive to the pre-processed organic feedstock; and (f) processing the pre-processed organic feedstock by pressurizing and heating the pre-processed organic feedstock to convert at least a portion of the algae to a fuel; and (g) extracting the fuel from the pre-processed and processed organic feedstock.
Patent NZ-614527-A (NZ)
Title: A roof tile
Inventor: CATHERINE MARY INGLIS
IPC: E04D1/34
Filed: 2013-08-20
Abstract: 614527 A roof tile (10) with a removable batten engaging device (26) is disclosed. The roof tile is generally square or rectangular in shape with a having top (11) and bottom surfaces in which the top surface is generally planar and the top and bottom surfaces are generally parallel. The tile has a pair of end edges and a pair of generally parallel side edges (14, 15) which are formed so that a side edge of one roof tile overlaps the side edge of another roof tile to form an overlapping region when the roof tiles are laid side-by-side. The removable batten engaging device engages the batten (26) with an abutment (43) which projects from the bottom surface of the roof tile and attaches to the tile by engaging with an opening in the top surface of the tile with a pin (40). The engaging device may be a pin such as a nail or screw. A roof made from a plurality of these tiles is also disclosed.
Patent NZ-615330-A (NZ)
Title: Delivery of respiratory therapy
Inventor: VELISS LEE JAMES
IPC: A61M16/06
Filed: 2007-12-14
Abstract: Disclosed is a respiratory mask for continuous positive airway pressure treatment for improved sealing around a wearer’s nasal airways. The mask comprises a cushion (80) adapted to be positioned against the face of a patient, the cushion being configured in a gasket arrangement around an entrance to the airways of the patient. The cushion includes an orifice (84) formed therein and configured to be positioned externally of the patient’s airways and in fluid communication therewith. The cushion is configured to engage an underside of the patient’s nose, and is constructed from foam that has a thickness of greater than about 5 mm. The cushion is attached to a support structure (82) and the support structure imparts curvature to the cushion. The foam is positioned to contact the skin directly and has an exposed open cellular structure to contact the patient’s skin. Lateral stabilizing portions are constructed from foam in one piece with the cushion.
Patent NZ-618487-A (NZ)
Title: Tip protector sleeve
Inventor: STOUT CHRISTOPHER A
IPC: A61F6/22
Filed: 2012-05-30
Abstract: A delivery catheter assembly (400) is disclosed in which a tip protector sleeve (300) is locked onto an elongated catheter sheath (404) and slideable over a length of the elongated catheter sheath between a proximal - stop position (402) and a distal -stop position (408) along the elongated catheter sheath. The present invention generally provide assemblies and methods of inserting a delivery catheter into a working channel of an endoscope, such as a hysteroscope system for accessing a female reproductive system. Advancement of the delivery catheter system within the uterus and the fallopian tubes is usually facilitated by distending the uterus with a distention fluid, such as saline, and viewing the placement with the hysteroscope system. During the proceedure fluid can spray onto the physician or physician’s assistant. The amount of fluid spray-back can be significant depending on the distention fluid pressure during the procedure. The delivery catheter assembly may include an interference stop which determines the distal-stop position and prevents the tip protector sleeve from sliding off of the distal end of the elongated catheter sheath. The tip protector sleeve may additionally incorporate a sealing valve to reduce the amount of fluid spray-back and leakage associated with inserting the delivery catheter assembly into the working channel of a hysteroscope system.
Patent NZ-628660-A (NZ)
Title: Bifunctional peptide
Inventor: HORNEBECK WILLIAM
IPC: C07K4/12
Filed: 2013-01-31
Abstract: Discloses a bifunctional peptide capable of activating the synthesis of collagen and inhibiting the production of matrix metallo-proteinases, wherein it has a sequence having three peptide portions A, B and C: - the first peptide portion A corresponding to a hexapeptide repeated at least three times, said portion A being capable of bonding to an elastin-binding receptor protein in order to stimulate the collagen synthesis, - the second peptide portion B corresponding to a tetrapeptide capable of acting as a competitive inhibitor of the urokinase protease and of being cleaved by said protease, and - the third peptide portion C corresponding to a tripeptide occupying at least one active site of the matrix metallo-proteinases in order to permit an inhibition of said proteinases. Also discloses cosmetic and pharmaceutical compositions comprising such a peptide, and related uses in treating scarring, pressure sores, or regenerating dermal tissues or the treatment of skin aging.